Metraipolis › archive › dc_f364c8403f6f
Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41280693
- DOI
- 10.1016/j.isci.2025.113754
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T08:27:50.319Z
- SHA-256 of the archived text
8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645- Stable URL of this page
https://metraipolis.com/documento/dc_f364c8403f6f
How to cite
Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693 — Europe PMC (en), https://europepmc.org/article/MED/41280693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f364c8403f6f (Metraipolis archive dc_f364c8403f6f, sha256 8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645)
BibTeX
@misc{dcf364c8403f6f,
title = {Use of microbiome analysis as a complementary endpoint in clinical trials — Europe PMC PMID:41280693},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41280693},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f364c8403f6f; sha256 8c3577652861ec1bb5cd2ca6abe3a4ee5ba7d022ad30eaee9fe028260af1f645},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41280693. Agents can read the archived copy with the MCP tool read_document.